166 related articles for article (PubMed ID: 33092755)
21. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
Käräjämäki AJ; Pätsi OP; Savolainen M; Kesäniemi YA; Huikuri H; Ukkola O
PLoS One; 2015; 10(11):e0142937. PubMed ID: 26571029
[TBL] [Abstract][Full Text] [Related]
22. The monocyte-to-high-density lipoprotein ratio is associated with the occurrence of atrial fibrillation among NAFLD patients: A propensity-matched analysis.
Wang L; Zhang Y; Yu B; Zhao J; Zhang W; Fan H; Ren Z; Liang B
Front Endocrinol (Lausanne); 2023; 14():1127425. PubMed ID: 37056665
[TBL] [Abstract][Full Text] [Related]
23. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.
Ullah W; Ling LH; Prabhu S; Lee G; Kistler P; Finlay MC; Earley MJ; Sporton S; Bashir Y; Betts TR; Rajappan K; Thomas G; Duncan E; Staniforth A; Mann I; Chow A; Lambiase P; Schilling RJ; Hunter RJ
Europace; 2016 May; 18(5):679-86. PubMed ID: 26843584
[TBL] [Abstract][Full Text] [Related]
24. Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study.
Lee SR; Han KD; Choi EK; Oh S; Lip GYH
Sci Rep; 2021 Feb; 11(1):3737. PubMed ID: 33580177
[TBL] [Abstract][Full Text] [Related]
25. Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis.
Donnellan E; Wazni O; Kanj M; Elshazly MB; Hussein A; Baranowski B; Hanna M; Patel D; Trulock K; Martyn M; Menon V; Saliba W; Jaber WA
Europace; 2020 Feb; 22(2):259-264. PubMed ID: 32031230
[TBL] [Abstract][Full Text] [Related]
26. Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study).
Creta A; Providência R; Adragão P; de Asmundis C; Chun J; Chierchia G; Defaye P; Schmidt B; Anselme F; Finlay M; Hunter RJ; Papageorgiou N; Lambiase PD; Schilling RJ; Combes S; Combes N; Albenque JP; Pozzilli P; Boveda S
Am J Cardiol; 2020 Mar; 125(6):901-906. PubMed ID: 31973808
[TBL] [Abstract][Full Text] [Related]
27. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation.
Fein AS; Shvilkin A; Shah D; Haffajee CI; Das S; Kumar K; Kramer DB; Zimetbaum PJ; Buxton AE; Josephson ME; Anter E
J Am Coll Cardiol; 2013 Jul; 62(4):300-5. PubMed ID: 23623910
[TBL] [Abstract][Full Text] [Related]
28. The impact of vagotonic, adrenergic, and random type of paroxysmal atrial fibrillation on left atrial ablation outcomes.
Efremidis M; Letsas KP; Lioni L; Deftereos S; Giannopoulos G; Kossyvakis C; Tsikrikas S; Charalampous C; Kollias G; Xydonas S; Synetos A; Sideris A; Toutouzas K; Stefanadis C
Int J Cardiol; 2013 Oct; 168(4):4015-8. PubMed ID: 23870637
[TBL] [Abstract][Full Text] [Related]
29. Geriatric nutritional risk index as a predictor of arrhythmia recurrence after catheter ablation of atrial fibrillation.
Kaneko M; Nagata Y; Nakamura T; Mitsui K; Nitta G; Nagase M; Okata S; Watanabe K; Miyazaki R; Nagamine S; Hara N; Lee T; Nozato T; Ashikaga T; Goya M; Hirao K; Sasano T
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1798-1808. PubMed ID: 33985896
[TBL] [Abstract][Full Text] [Related]
30. Relation of Left Atrial Appendage Remodeling by Magnetic Resonance Imaging and Outcome of Ablation for Atrial Fibrillation.
Suksaranjit P; Marrouche NF; Han FT; Morris A; Kaur G; Oswald T; Wilson BD
Am J Cardiol; 2018 Jul; 122(1):83-88. PubMed ID: 29731119
[TBL] [Abstract][Full Text] [Related]
31. Catheter ablation of atrial fibrillation in very young adults: a 5-year follow-up study.
Saguner AM; Maurer T; Wissner E; Santoro F; Lemes C; Mathew S; Sohns C; Heeger CH; Reißmann B; Riedl J; Fink T; Hayashi K; Wohlmuth P; Kuck KH; Ouyang F; Metzner A
Europace; 2018 Jan; 20(1):58-64. PubMed ID: 28017937
[TBL] [Abstract][Full Text] [Related]
32. Impacts of the body size on the left atrial wall thickness and atrial fibrillation recurrence after catheter ablation.
Nakatani Y; Sakamoto T; Yamaguchi Y; Tsujino Y; Kataoka N; Nishida K; Mizumaki K; Kinugawa K
Heart Vessels; 2019 Aug; 34(8):1351-1359. PubMed ID: 30737525
[TBL] [Abstract][Full Text] [Related]
33. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
34. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
[TBL] [Abstract][Full Text] [Related]
36. Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.
Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Rodella S; Zoppini G; Mantovani W; Barbieri E; Byrne CD
PLoS One; 2013; 8(2):e57183. PubMed ID: 23451184
[TBL] [Abstract][Full Text] [Related]
37. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
Marrouche NF; Wilber D; Hindricks G; Jais P; Akoum N; Marchlinski F; Kholmovski E; Burgon N; Hu N; Mont L; Deneke T; Duytschaever M; Neumann T; Mansour M; Mahnkopf C; Herweg B; Daoud E; Wissner E; Bansmann P; Brachmann J
JAMA; 2014 Feb; 311(5):498-506. PubMed ID: 24496537
[TBL] [Abstract][Full Text] [Related]
38. Five-year follow-up outcome after catheter ablation of persistent atrial fibrillation using a sequential biatrial linear defragmentation approach: What does atrial fibrillation termination during the procedure imply?
Miyazaki S; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Hirao K; Iesaka Y
Heart Rhythm; 2017 Jan; 14(1):34-40. PubMed ID: 27590435
[TBL] [Abstract][Full Text] [Related]
39. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
[TBL] [Abstract][Full Text] [Related]
40. Age-Dependent Predictive Value of Endothelial Dysfunction for Arrhythmia Recurrence Following Pulmonary Vein Isolation.
Matsuzawa Y; Suleiman M; Guddeti RR; Kwon TG; Monahan KH; Lerman LO; Friedman PA; Lerman A
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27613771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
